2013-07542. New Animal Drugs; Change of Sponsor  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Final rule.

    SUMMARY:

    The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for 43 approved new animal drug applications (NADAs) and 3 approved abbreviated new animal drug applications (ANADAs) from Boehringer Ingelheim Vetmedica, Inc. to Strategic Veterinary Pharmaceuticals, Inc.

    DATES:

    This rule is effective April 9, 2013.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Steven D. Vaughn, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7520 Standish Pl., Rockville, MD 20855, 240-276-8300, email: steven.vaughn@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    Boehringer Ingelheim Vetmedica, Inc., 2621 North Belt Highway, St. Joseph, MO 64506-2002 has informed FDA that it has transferred ownership of, and all rights and interest in, the following 43 approved NADAs and 3 approved ANADAs to Strategic Veterinary Pharmaceuticals, Inc., 100 NW. Airport Rd., St. Joseph, MO 64503:

    Table 1.—Applications Transferred

    Application No.Trade name
    11-531DIZAN (dithiazanine iodide) Tablets.
    11-674DIZAN (dithiazanine iodide) Powder.
    12-469DIZAN Suspension With Piperazine.
    31-512ATGARD (dichlovos) Swine Wormer Type A Medicated Article.
    33-803TASK (dichlovos) Dog Anthelmintic.
    35-918EQUIGARD (dichlovos).
    38-200MEDAMYCIN (oxytetracycline hydrochloride) Soluble Antibiotic.
    39-483BIO-TAL (thiamylal sodium) Injectable Solution.
    40-848ATGARD C (dichlovos) Swine Wormer Type A Medicated Article.
    43-606ATGARD V (dichlovos) Swine Wormer Type A Medicated Article.
    45-143OXYJECT (oxytetracycline hydrochloride) Injectable Solution.
    47-278OXY-TET 50 (oxytetracycline hydrochloride) Injectable Solution.
    47-712BIZOLIN-100 (phenylbutazone) Tablets.
    48-010ANAPLEX (dichlorophene and toluene) Capsules.
    48-237EQUIGEL (dichlovos) Oral Gel.
    48-271TASK (dichlovos) Tablets.
    49-032ATGARD C (dichlovos) 9.6% Type A Medicated Article.
    55-097DRY-MAST (penicillin G procaine/dihydrostreptomycin sulfate) Intramammary Infusion.
    65-178FERMYCIN (chlortetracycline hydrochloride or chlortetracycline bisulfate) Soluble Powder.
    65-461ANACETIN (chloramphenicol) Tablets.
    65-481Chlortetracycline Pneumonia/Calf Scour Boluses.
    65-486Chlortetracycline Bisulfate Soluble Powder.
    65-491MEDICHOL (chloramphenicol) Tablets.
    65-496Tetracycline Soluble Powder.
    92-837NEMACIDE (diethylcarbamazine citrate) Oral Syrup.
    93-516BIZOLIN (phenylbutazone) Injection 20%.
    97-452OXYJECT 100 (oxytetracycline hydrochloride) Injectable Solution.
    98-569MEDACIDE-SDM (sulfadimethoxine) Injection 10%.
    99-618BIZOLIN (phenylbutazone) 1-G Tablets.
    108-963MEDAMYCIN (oxytetracycline hydrochloride) Injectable Solution.
    Start Printed Page 21059
    109-305Oxytocin Injection.
    117-689NEUROSYN (primidone) Tablets.
    125-797Nitrofurazone Dressing.
    126-236Nitrofurazone Soluble Powder.
    126-676D & T (dichlorophene and toluene) Worm Capsules.
    127-627NEMACIDE-C (diethylcarbamazine citrate) Tablets.
    128-069NEMACIDE (diethylcarbamazine citrate) Chewable Tablets.
    132-028ANESTATAL (thiamylal sodium) Powder for Injection.
    135-771Methylprednisolene Tablets.
    136-212Methylprednisolone Acetate Injectable Suspension.
    137-310Gentamicin Sulfate Injectable Solution.
    138-869Triamcinolone Acetonide Injectable Suspension.
    140-442Xylazine HCl Injection.
    200-023Gentamicin Sulfate Intrauterine Solution.
    200-029Ketamine Hydrochloride Injection.
    200-165SDM (sulfadimethoxine) 12.5% Oral Solution.

    Accordingly, the Agency is amending the regulations in 21 CFR parts 510, 520, 522, 524, 526, 529, and 558 to reflect the transfer of ownership.

    This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

    Start List of Subjects

    List of Subjects

    21 CFR Part 510

    • Administrative practice and procedure
    • Animal drugs
    • Labeling
    • Reporting and recordkeeping requirements

    21 CFR Parts 520, 522, 524, 526, and 529

    • Animal drugs

    21 CFR Part 558

    • Animal drugs
    • Animal feeds
    End List of Subjects

    Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510, 520, 522, 524, 526, 529, and 558 are amended as follows:

    Start Part

    PART 510—NEW ANIMAL DRUGS

    End Part Start Amendment Part

    1. The authority citation for 21 CFR part 510 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

    End Authority Start Amendment Part

    2. In the table in paragraph (c)(1) of § 510.600, alphabetically add an entry for “Strategic Veterinary Pharmaceuticals, Inc.”; and in the table in paragraph (c)(2), numerically add an entry for “054628” to read as follows:

    End Amendment Part
    Names, addresses, and drug labeler codes of sponsors of approved applications.
    * * * * *

    (c) * * *

    (1) * * *

    Firm name and addressDrug labeler code
    *    *    *    *    *
    Strategic Veterinary Pharmaceuticals, Inc., 100 NW. Airport Rd., St. Joseph, MO 64503054628
    *    *    *    *    *

    (2) * * *

    Drug labeler codeFirm name and address
    *    *    *    *    *
    054628Strategic Veterinary Pharmaceuticals, Inc., 100 NW. Airport Rd., St. Joseph, MO 64503
    *    *    *    *    *
    Start Part

    PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS

    End Part Start Amendment Part

    3. The authority citation for 21 CFR part 520 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 360b.

    End Authority
    [Amended]
    Start Amendment Part

    4. In paragraph (b)(1)(i) of § 520.390a, remove “000010” and in its place add “054628”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    5. In paragraph (b)(3) of § 520.441, remove “000010” and in its place add “054628”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    6. In paragraph (b) of § 520.443, remove “000010” and in its place add “054628”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    7. In paragraph (b)(2), remove “000010 and 000061” and in its place add “Nos. 000061 and 054628”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    8. In paragraph (c) of § 520.600, remove “000010” and in its place add “054628”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    9. In paragraph (a)(6) of § 520.622a, remove “000010” and in its place add “054628”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    10. In paragraph (c)(2) of § 520.622b, remove “000010” and in its place add “054628”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    11. In paragraph (b)(6) of § 520.622c, remove “000010” and in its place add “054628”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    12. In § 520.763a, remove and reserve paragraph (a); in paragraph (c), remove “000010” and in its place add “054628”; and remove paragraph (e).

    End Amendment Part
    [Amended]
    Start Amendment Part

    13. In § 520.763b, remove and reserve paragraph (a); and in paragraph (c), remove “000010” and in its place add “054628”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    14. In paragraph (b) of § 520.763c, remove “000010” and in its place add “054628”; and remove and reserve paragraph (c).

    End Amendment Part
    Start Printed Page 21060
    [Amended]
    Start Amendment Part

    15. In paragraph (b) of § 520.1408, remove “000010” and in its place add “054628”; and remove and reserve paragraph (c).

    End Amendment Part
    [Amended]
    Start Amendment Part

    16. In § 520.1660d:

    End Amendment Part Start Amendment Part

    a. In paragraph (b)(3), remove “000010” and in its place add “054628”.

    End Amendment Part Start Amendment Part

    b. In paragraph (d)(1)(ii)(A)( 3), remove “000010” and in its place add “054628”.

    End Amendment Part Start Amendment Part

    c. In paragraph (d)(1)(ii)(B)( 3), remove “000010” and in its place add “054628”.

    End Amendment Part Start Amendment Part

    d. In paragraph (d)(1)(ii)(C)( 3), remove “000010” and in its place add “054628”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    17. In paragraph (b)(2) of § 520.1720a, remove “000010 and 000859” and in its place add “000859 and 054628”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    18. In paragraph (b) of § 520.1900, remove “000010” and in its place add “054628”; and in paragraphs (c)(1), (c)(2), and (c)(3), remove the footnote.

    End Amendment Part
    [Amended]
    Start Amendment Part

    19. In paragraph (a)(1) of § 520.2220a, remove “000010, 000069, 000859, 054925, and 057561” and in its place add “000069, 000859, 054628, 054925, and 057561”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    20. In paragraph (b)(2) of § 520.2345d, remove “000010” and in its place add “054628”.

    End Amendment Part Start Part

    PART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS

    End Part Start Amendment Part

    21. The authority citation for 21 CFR part 522 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 360b.

    End Authority
    [Amended]
    Start Amendment Part

    22. In paragraph (b)(3) of § 522.1044, remove “000010” and in its place add “054628”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    23. In paragraph (b) of § 522.1222a, remove “000010, 000859, 061690, 026637, and 063286” and in its place add “000859, 026637, 054628, 061690, and 063286”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    24. In paragraph (b) of § 522.1410, remove “000010” and in its place add “054628”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    25. In paragraphs (a)(2), (b)(2), (g)(2), and (h)(2) of § 522.1662a, remove “000010” and in its place add “054628”.

    End Amendment Part Start Amendment Part

    26. In § 522.1680, revise the section heading to read as set forth below; and in paragraph (b), remove “000010, 000856, 000859, and 061623” and in its place add “000856, 000859, 054628, and 061623”.

    End Amendment Part
    Oxytocin.
    * * * * *
    Start Amendment Part

    27. In § 522.1720, revise the section heading to read as set forth below; and in paragraph (b)(2), remove “000010” and in its place add “054628”.

    End Amendment Part
    Phenylbutazone.
    * * * * *
    Start Amendment Part

    28. In § 522.2220, revise the section heading as set forth below; and in paragraph (c)(2), remove “000010” and in its place add “054628”.

    End Amendment Part
    Sulfadimethoxine.
    * * * * *
    Start Amendment Part

    29. In § 522.2424, revise the section heading as set forth below; and in paragraph (b), remove “000010 and 000856” and in its place add “000856 and 054628”; and remove paragraph (c)(4).

    End Amendment Part
    Sodium thiamylal.
    * * * * *
    [Amended]
    Start Amendment Part

    30. In paragraph (b) of § 522.2483, remove “000010” and in its place add “054628”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    31. In paragraph (b)(1) of § 522.2662, remove “000010” and in its place add “054628”.

    End Amendment Part Start Part

    PART 524—OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS

    End Part Start Amendment Part

    32. The authority citation for 21 CFR part 524 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 360b.

    End Authority
    [Amended]
    Start Amendment Part

    33. In paragraph (b)(1) of § 524.1580b, remove “000010, 000069, 050749, 054925, 058005, and 061623” and in its place add “000069, 050749, 054628, 054925, 058005, and 061623”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    34. In paragraph (b) of § 524.1580c, remove “000010 and 000069” and in its place add “000069 and 054628”.

    End Amendment Part Start Part

    PART 526—INTRAMAMMARY DOSAGE FORM NEW ANIMAL DRUGS

    End Part Start Amendment Part

    35. The authority citation for 21 CFR part 526 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 360b.

    End Authority
    [Amended]
    Start Amendment Part

    36. In paragraph (b) of § 526.1696b, remove “000010” and in its place add “054628”.

    End Amendment Part Start Part

    PART 529—CERTAIN OTHER DOSAGE FORM NEW ANIMAL DRUGS

    End Part Start Amendment Part

    37. The authority citation for 21 CFR part 529 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 360b.

    End Authority
    [Amended]
    Start Amendment Part

    38. In paragraph (b) of § 529.1044a, remove “000010, 000061, 000856, 000859 057561, 058005, and 061623” and in its place add “000061, 000856, 000859, 054628, 057561, 058005, and 061623”.

    End Amendment Part Start Part

    PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

    End Part Start Amendment Part

    39. The authority citation for 21 CFR part 558 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 360b, 371.

    End Authority
    [Amended]
    Start Amendment Part

    40. In paragraph (a) of § 558.205, remove “000010” and in its place add “054628”.

    End Amendment Part Start Signature

    Dated: March 26, 2013.

    Steven D. Vaughn,

    Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.

    End Signature End Supplemental Information

    [FR Doc. 2013-07542 Filed 4-8-13; 8:45 am]

    BILLING CODE 4160-01-P

Document Information

Comments Received:
0 Comments
Effective Date:
4/9/2013
Published:
04/09/2013
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule.
Document Number:
2013-07542
Dates:
This rule is effective April 9, 2013.
Pages:
21058-21060 (3 pages)
Docket Numbers:
Docket No. FDA-2013-N-0002
Topics:
Administrative practice and procedure, Animal drugs, Animal feeds, Labeling, Reporting and recordkeeping requirements
PDF File:
2013-07542.pdf
Supporting Documents:
» FREEDOM OF INFORMATION SUMMARY NADA 130-185 AMPROL 25% and FLAVOMYCIN Amprolium and Bambermycins
» FREEDOM OF INFORMATION SUMMARY Application Number 141-422 PACCAL VET-CA1 Paclitaxel for injection Powder for Injection Dog
» FREEDOM OF INFORMATION SUMMARY NADA141-420 TILDREN tiludronate disodium Powder for injection Horse
» FREEDOM OF INFORMATION SUMMARY NADA 141-361 PULMOTIL AC Tilmicosin Phosphate Aqueous Concentrate Swine
» FREEDOM OF INFORMATION SUMMARY NADA 141-246 AQUAFLOR Florfenicol
» Freedom of Information Summary NADA 141-288 EXCENEL RTU EZ Ceftiofur Hydrochloride
» Freedom of Information Summary NADA 095-735 RUMENSIN 90 Monensin
» Freedom of Information Summary NADA 141-406 NEXGARD Afoxolaner Chewable Tablet
» Freedom of Information Summary ANADA 200-548 ACTOGAIN 45 Ractopamine Hydrochloride Cattle fed in confinement for slaughter
» Freedom of Information Summary ANADA 200-542 ENGAIN 9 and ENGAIN 5 Ractopamine Hydrochloride Finishing Swine
CFR: (33)
21 CFR 510.600
21 CFR 520.441
21 CFR 520.443
21 CFR 520.580
21 CFR 520.600
More ...